Anderson Kenneth Carl 4
4 · C4 Therapeutics, Inc. · Filed Oct 3, 2023
Insider Transaction Report
Form 4
Anderson Kenneth Carl
Director
Transactions
- Award
Common Stock
2023-10-02$1.70/sh+6,617$11,249→ 109,237 total
Holdings
- 61,265(indirect: By Trust)
Common Stock
- 61,265(indirect: By Trust)
Common Stock
- 16,939(indirect: By Trust)
Common Stock
- 47,316(indirect: By Spouse)
Common Stock
- 16,939(indirect: By Trust)
Common Stock
Footnotes (6)
- [F1]These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.
- [F2]The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 2, 2023.
- [F3]Shares held by the Kenneth C. Anderson 2016 Grantor Retained Annuity Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F4]Shares held by the Cynthia E. Anderson 2016 Grantor Retained Annuity Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F5]Shares held by the Kenneth C. Anderson 2015 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F6]Shares held by the Cynthia E. Anderson 2015 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.